Vanberra Signal

Cellogy

Curated by Signal

Stem cell-based modeling using machine learning

Overview

Cellogy is a biotechnology startup advancing stem cell-based modeling of human disease through quantitative imaging and machine learning. Cellogy’s first product, called Pulse, performs automated characterization of stem cell-derived cardiomyocytes using video microscopy and state-of-the-art computer vision analysis. In addition to Pulse, Cellogy is developing other innovative products to address the growing need for automated, large-scale analysis of stem cells and differentiated cells.

Key facts

Founded
2012

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Non-invasive neuromodulation through transcranial magnetic stimulation to treat treatment resistant depression

    Life Sciences TechnologyRedwood City, United States
  • Developer of genetic testing kit for Alzheimer's disease and COVID-19

    Life Sciences TechnologyBellingham, United States
  • Developer of therapeutics for cancer and immunology disorders

    Life Sciences TechnologyBoston, United States

About Cellogy

What does Cellogy do?

Cellogy is a biotechnology startup advancing stem cell-based modeling of human disease through quantitative imaging and machine learning.

Where is Cellogy headquartered?

Cellogy is headquartered in Menlo Park, United States.

When was Cellogy founded?

Cellogy was founded in 2012.

Which sector is Cellogy in?

Cellogy operates in Life Sciences Technology.

Who are Cellogy's competitors?

Companies similar to Cellogy include Cervel, ADx Health, and Psivant.